On 17 November 2026 the ADGM Registration Authority opened a consultation on its cell companies framework. The proposals move operational rules into a new rulebook and would let an incorporated cell use its cell company's registered office. Comments close on 10 December 2026.
The short answer
- The ADGM Registration Authority published Consultation Paper No. 10 of 2026 on 17 November 2026. Comments close on 10 December 2026.
- Part 36 of the Companies Regulations 2020 would keep the substantive law on cell companies, and a new set of Cell Companies Rules would hold the operational and administrative provisions.
- An incorporated cell would no longer need its own registered office. It could use the registered office of its incorporated cell company, or another address in ADGM.
- The paper also asks whether cell companies should be restricted to particular business activities or sectors.
- These are proposals. The Registration Authority says not to act on them until the final regulations and rules are issued.
Last reviewed 21 November 2026
ADGM Registration Authority Consultation Paper No. 10 of 2026 proposes to reorganise ADGM's cell companies framework. The substantive law would stay in Part 36 of the Companies Regulations 2020, operational and administrative provisions would move into new Cell Companies Rules, and an incorporated cell would be allowed to use its cell company's registered office. Comments close on 10 December 2026.
The Registration Authority (the RA) published the paper on 17 November 2026. It says the proposals respond to the increasing use of protected cell companies and incorporated cell companies in ADGM. The RA's announcement and the consultation paper are the primary sources for everything below.
What is a cell company?
A cell company lets one structure hold several pools of assets, with each pool kept apart from the others. ADGM has two kinds.
| Protected cell company (PCC) | Incorporated cell company (ICC) | |
|---|---|---|
| Legal personality | One legal person, with cells inside it | Each incorporated cell is its own legal person |
| What a cell is | A ring-fenced pool of assets and liabilities | A separate company linked to the ICC |
| Typical uses | Funds, insurance, asset holding | Funds, asset holding, family structures where a cell contracts in its own name |
The RA names fund, insurance, asset-holding and family office structures as the users of cell companies in ADGM.
What is the RA proposing?
The paper sets out three main changes.
1. Part 36 keeps the substantive law. Part 36 of the Companies Regulations 2020 would continue to contain the corporate law that governs cell companies and cells: the legal rights, liabilities and protections. It would also gain a new rule-making power covering how cell companies are administered and operated, including the procedure for setting them up.
2. New Cell Companies Rules hold the procedure. A standalone set of rules, the Companies Regulations (Cell Companies) Rules 2026, would contain the operational and administrative provisions. The RA lists the creation and registration of cells, registers, confirmation statements, accounting records, accounts, filings, names and changes of status.
3. An incorporated cell could share a registered office. An incorporated cell would not be required to maintain a separate registered office. It could use the registered office of its incorporated cell company, or specify another address in ADGM. The paper includes consequential arrangements for notices and for changes of registered office.
The RA says the aim is to make the framework easier to find, read and use, and to keep it commercially practical and competitive, while retaining the legal protections that apply to members, creditors and other third parties.
Why the registered office change matters
Today, each incorporated cell is a separate legal person, so a structure with several cells can carry several registered offices to maintain. If the proposal is adopted, a structure could run every cell from one address. For a family or a manager with several cells, that would mean fewer addresses to keep and fewer notices to route.
It would not remove each cell's own records. Registers, confirmation statements and accounts for cells are among the subjects the new rules would cover, so read the draft rules before assuming an obligation has gone.
The question about restricting use
One of the seven consultation questions asks whether the use of cell companies should be restricted to specified business activities or sectors, and if so, which and on what basis. The RA has not proposed a restriction, but it is asking. Anyone who uses, or plans to use, a cell company outside funds and insurance should take note of that question and consider responding.
Who is affected?
- Existing protected cell companies and incorporated cell companies, and their cells
- Anyone planning a cell company structure in ADGM
- Fund, insurance, asset-holding and family office structures that use or may use cell companies
- Their members and professional advisers
How to respond before 10 December 2026
- Read the consultation paper, the blackline of Part 36 and the draft Cell Companies Rules, which are in the materials on the consultation page.
- Register on the RA Consultation Portal. Registration is a one-time step.
- Submit comments through the portal by 10 December 2026. The RA says comments sent by email may not be considered.
What happens next?
After the deadline the RA will review the comments and consider whether to modify the proposals. The ADGM Board of Directors and the Registrar will then enact the proposals in their final form. The RA is clear that you should not act on the proposed amendments until the final regulations, rules and any related guidance are published.
How this compares with the DIFC
The DIFC offers a similar idea through its Variable Capital Company, which can be an umbrella structure with either Segregated Cells or Incorporated Cells. Our DIFC Variable Capital Company guide explains how those cells work, and DIFC SPV or ADGM SPV compares the simpler single-asset vehicles in each centre.
How Atlas helps
Atlas keeps the registered office, company secretarial and filing records for the ADGM and DIFC entities we look after. If you have a cell structure in ADGM, we can help you check which registered offices and filings it carries today, and which would change if the proposals are adopted. Our ADGM corporate services page sets out the structures we establish and administer there. We do not give legal or regulatory advice or draft consultation responses, so for views on the drafts themselves please speak to your legal adviser.
This article is general information and does not constitute legal, tax or regulatory advice. It summarises a consultation paper and draft rules that may change before they are made final. Check the final regulations and rules issued by the ADGM Registration Authority before acting.
Frequently Asked Questions
What is ADGM Consultation Paper No. 10 of 2026?
It is a consultation by the ADGM Registration Authority on proposed amendments to Part 36 of the Companies Regulations 2020 and on new Companies Regulations (Cell Companies) Rules 2026. It opened on 17 November 2026 and closes on 10 December 2026.
What would change for incorporated cells in ADGM?
Under the proposals, an incorporated cell would not have to maintain a separate registered office. It could use the registered office of its incorporated cell company, or specify another address in ADGM. The paper also proposes consequential arrangements for notices and changes of registered office.
What is the difference between a protected cell company and an incorporated cell company?
A protected cell company is one legal person whose cells keep assets and liabilities apart from each other. In an incorporated cell company, each incorporated cell is a separate legal person. Both let one structure hold several pools of assets without one pool being exposed to another's liabilities.
Who should read the consultation?
The Registration Authority names existing and prospective protected cell companies and incorporated cell companies, their cells, members and professional advisers, and fund, insurance, asset-holding and family office structures that use or may use cell companies.
How do I respond to the consultation?
Comments must be submitted through the Registration Authority's Consultation Portal, which needs a one-time registration. The Registration Authority says comments sent by email may not be considered. The deadline is 10 December 2026.

